Sensus Q3 2025: Revenue down 21.6% to $6.9M; net loss of $0.9M vs profit of $1.2M a year ago

Sensus Healthcare, Inc.

2025-Q3 EPS reported -$0.28 revenue$22,543,000

Net loss of $0.9M ($0.06 per share) vs net income of $1.2M ($0.07 diluted) in Q3 2024.
Revenue fell 21.6% to $6.9M; gross margin dropped to 39.1% from 59.1%.
Shipped 16 SRT systems (vs 27 last year), including 3 to China; 21 FDA sites active.
CMS published first-ever dedicated CPT® codes for SRT, improving reimbursement certainty.
Exited quarter with $24.5M cash, no debt; nearly 100 systems in inventory.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.